Search results
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 6 days agoA decade ago, as British drugmaker AstraZeneca fought off a hostile takeover bid by Pfizer, CEO Pascal Soriot made a big promise: The company, he said,...
AstraZeneca to build $1.5 bln cancer drug facility in Singapore
Medical Xpress· 7 days agoBritish pharmaceutical giant AstraZeneca said Monday that it planned to build a $1.5 billion plant...
AstraZeneca Rises to Record High After Announcing Plans for 'New Era of Growth'
Investopedia· 6 days agoAstraZeneca's (AZN) American depositary receipts (ADRs) rose over 2% to a record high Tuesday after...
'New era of growth': AstraZeneca sets out bold plans for $80bn revenues by 2030
Evening Standard via Yahoo Finance· 6 days agoThe biggest company on London’s stock market, AstraZeneca, set out bold plans today for what it’s...
AstraZeneca aims to deliver $80 billion in total revenue by 2030
KFGO· 6 days ago(Reuters) -AstraZeneca said on Tuesday it expects to deliver $80 billion in total revenue by 2030,...
AstraZeneca to establish $1.5bn ADC production site in Singapore
Pharmaceutical Technology via Yahoo Finance· 6 days agoAstraZeneca is set to invest $1.5bn in a new manufacturing facility in Singapore dedicated to...
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 5 days agoDive Brief: AstraZeneca’s plan to reach $80 billion in sales by 2030 relies heavily on a slate of...
AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
Zacks· 6 days agoFree Report) announced its long-term plan to generate $80 billion in total revenues by 2030, which is significantly higher than $43.8 million generated in 2023. By 2030, AstraZeneca ...
Why Astrazeneca (AZN) is a Great Dividend Stock Right Now
Zacks via Yahoo Finance· 4 days agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is...
Pfizer wins cancer drug patent case against AstraZeneca
Pharmaceutical Technology via Yahoo Finance· 7 days agoThe US District Court for the District of Delaware has ordered AstraZeneca to pay $107.5m to Pfizer...